Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market. Its crop yield traits are utilized by its partners to develop higher-yielding seeds for global crops, including wheat, rice, soybean, corn, and sugarcane, as well as for other crops, such as cotton, turf, and trees. The Company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency, Water Use Efficiency, Drought Tolerance, Salinity Tolerance and Herbicide Tolerance. 
Type
Public
HQ
Davis, US
Founded
2015
Size (employees)
57 (est)
Arcadia Biosciences was founded in 2015 and is headquartered in Davis, US
Report incorrect company information

Key People/Management at Arcadia Biosciences

Vic Knauf

Vic Knauf

Chief Scientific Officer
Zhongjin Lu

Zhongjin Lu

Vice President of Product Development
Don Emlay

Don Emlay

Vice President of Regulatory Affairs

Arcadia Biosciences Office Locations

Arcadia Biosciences has an office in Davis
Davis, US (HQ)
105 202 Cousteau Pl
Show all (1)
Report incorrect company information

Arcadia Biosciences Financials and Metrics

Arcadia Biosciences Financials

Arcadia Biosciences's revenue was reported to be $4.03 m in FY, 2017
USD

Revenue (FY, 2017)

4 m

EBIT (FY, 2017)

(14.3 m)

Market capitalization (25-Apr-2018)

35.4 m

Cash (31-Dec-2017)

9.1 m
Arcadia Biosciences's current market capitalization is $35.4 m.
Annual
USDFY, 2015FY, 2016FY, 2017

Revenue

5.4 m3.2 m4 m

Revenue growth, %

(41%)

General and administrative expense

11.1 m12.3 m10.7 m

R&D expense

9 m8.7 m7.4 m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

815 k1.4 m1.8 m852 k721 k1.1 m1 m991 k

General and administrative expense

2.6 m2.8 m2.8 m3.4 m2.8 m2.7 m3.1 m2.9 m

R&D expense

1.8 m2.1 m3.2 m2.2 m2.2 m2.3 m1.8 m1.7 m

Operating expense total

4.5 m5 m6.1 m5.8 m5 m5 m5 m4.7 m
Annual
USDFY, 2015FY, 2016FY, 2017

Cash

24 m2 m9.1 m

Accounts Receivable

706 k349 k1.2 m

Inventories

692 k877 k

Current Assets

52 m52.2 m15 m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

11.3 m80 m63 m29.5 m27.4 m10.5 m7.6 m13.4 m

Accounts Receivable

150 k145 k685 k587 k177 k97 k284 k432 k

Current Assets

12.4 m81.6 m76.6 m52.5 m56.2 m55.7 m50.4 m46.5 m

PP&E

663 k633 k597 k656 k636 k580 k486 k417 k
Annual
USDFY, 2015FY, 2016FY, 2017

Net Income

(18 m)(19.6 m)(15.7 m)

Depreciation and Amortization

294 k304 k279 k

Inventories

412 k582 k183 k

Accounts Payable

125 k(19 k)87 k
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(5.2 m)(4.6 m)(4.2 m)

Accounts Payable

3.4 m4.7 m4 m2.8 m2.6 m2.6 m2.2 m
USDY, 2017

Revenue/Employee

70.6 k

Financial Leverage

2.1 x
Show all financial metrics
Report incorrect company information

Arcadia Biosciences News and Updates

Report incorrect company information